Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07200466Not ApplicableRecruiting

Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation

Role: collaborator

NCT07252245Not ApplicableNot Yet Recruiting

Pre Hospital Triage of Patients at Intermediate and High Risk for ACS

Role: collaborator

NCT03938168Completed

Histological and Molecular Mechanisms of Pain in Patient With Chronic Pain From Adhesions

Role: collaborator

NCT05121805Not ApplicableUnknown

Recurrences After Standard EMR vs Plus Thermal Ablation EMR

Role: collaborator

NCT04698954Not ApplicableCompleted

Evaluating the Adherence Improving Self-Management Strategy Intervention in Chronic Heart Failure Patients

Role: collaborator

NCT02508675Unknown

Non-fatal Outcome After Trauma

Role: collaborator

All 6 trials loaded